![]()
|
|
||||||||
(Received for publication, June 6, 1996, and in revised form, August 16, 1996)
From the Experimental Immunology Branch, DBS, NCI, National
Institutes of Health, Bethesda, Maryland 20892-1360
Human neuronal cells express neither major
histocompatibility complex (MHC) class I RNA nor cell surface molecules
but can be induced to do so by various cytokines. In the present
studies, we report that expression of MHC class I in a neuroblastoma
cell line, CHP-126, is actively repressed. This repression is mediated by the combined effects of a series of upstream silencer elements. Removal of the silencers reveals not only an active promoter element but also the presence of an active enhancer. Four silencers have been
identified and shown to have distinct sequences, binding factors, and
patterns of function. One element is located between
Volume 271, Number 48,
Issue of November 29, 1996
pp. 30992-30999
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
724 and
697
base pairs (bp) and corresponds to a silencer involved in
tissue-specific regulation of class I gene expression. Three additional
elements occur between
503 and
402 bp. One of these corresponds to
a c-jun responsive element. Neither of the remaining elements corresponds to DNA sequences known to regulate expression of
other genes. These data demonstrate that MHC class I expression normally is actively repressed in neuronal cells and suggest a model of
rapid and specific triggering of class I in neuronal cells in response
to infection.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
N. Huebener, S. Fest, A. Strandsby, E. Michalsky, R. Preissner, Y. Zeng, G. Gaedicke, and H. N. Lode A rationally designed tyrosine hydroxylase DNA vaccine induces specific antineuroblastoma immunity Mol. Cancer Ther., July 1, 2008; 7(7): 2241 - 2251. [Abstract] [Full Text] [PDF] |
||||
![]() |
C Giuliani, M Saji, I Bucci, G Fiore, M Liberatore, D S Singer, F Monaco, L D Kohn, and G Napolitano Transcriptional regulation of major histocompatibility complex class I gene by insulin and IGF-I in FRTL-5 thyroid cells. J. Endocrinol., June 1, 2006; 189(3): 605 - 615. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. K. Howcroft, A. Raval, J. D. Weissman, A. Gegonne, and D. S. Singer Distinct Transcriptional Pathways Regulate Basal and Activated Major Histocompatibility Complex Class I Expression Mol. Cell. Biol., May 15, 2003; 23(10): 3377 - 3391. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yazawa, T. Ito, H. Kamma, T. Suzuki, K. Okudela, H. Hayashi, H. Horiguchi, T. Ogata, H. Mitsui, M. Ikeda, et al. Complicated Mechanisms of Class II Transactivator Transcription Deficiency in Small Cell Lung Cancer and Neuroblastoma Am. J. Pathol., July 1, 2002; 161(1): 291 - 300. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. J. Magner, A. L. Kazim, C. Stewart, M. A. Romano, G. Catalano, C. Grande, N. Keiser, F. Santaniello, and T. B. Tomasi Activation of MHC Class I, II, and CD40 Gene Expression by Histone Deacetylase Inhibitors J. Immunol., December 15, 2000; 165(12): 7017 - 7024. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Weissman, T. K. Howcroft, and D. S. Singer TAFII250-independent Transcription Can Be Conferred on a TAFII250-dependent Basal Promoter by Upstream Activators J. Biol. Chem., March 31, 2000; 275(14): 10160 - 10167. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. K. Howcroft, C. Murphy, J. D. Weissman, S. J. Huber, M. Sawadogo, and D. S. Singer Upstream Stimulatory Factor Regulates Major Histocompatibility Complex Class I Gene Expression: the U2Delta E4 Splice Variant Abrogates E-Box Activity Mol. Cell. Biol., July 1, 1999; 19(7): 4788 - 4797. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Schreiber, A. Kolbus, F. Piu, A. Szabowski, U. Möhle-Steinlein, J. Tian, M. Karin, P. Angel, and E. F. Wagner Control of cell cycle progression by c-Jun is p53 dependent Genes & Dev., March 1, 1999; 13(5): 607 - 619. [Abstract] [Full Text] |
||||
![]() |
H. N. Lode, R. Xiang, T. Dreier, N. M. Varki, S. D. Gillies, and R. A. Reisfeld Natural Killer Cell-Mediated Eradication of Neuroblastoma Metastases to Bone Marrow by Targeted Interleukin-2 Therapy Blood, March 1, 1998; 91(5): 1706 - 1715. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Dong, Q. Ma, and J. P. Whitlock Jr. Down-regulation of Major Histocompatibility Complex Q1b Gene Expression by 2,3,7,8-Tetrachlorodibenzo-p-dioxin J. Biol. Chem., November 21, 1997; 272(47): 29614 - 29619. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |